Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents with Insulin Resistance
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) · 01.05.2026 · 10 (2) · 184-191
DOI: 10.54133/ajms.v10i2.2841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), online erschienen am 01.05.2026. Verfasst von Ghasak Kais Abd-Alhussain. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Acanthosis nigricans (AN) is a well-known skin condition characterized by the development of hyperpigmented skin patches associated with abnormal texture and is closely related to metabolic syndromes characterized by insulin resistance. Chromium picolinate supplementation, especially, is suggested to improve insulin function in peripheral tissue by stimulating the insulin receptors. Which might ultimately improve the severity of acanthosis nigricans. There is not enough evidence to support the significance of this correlation.
Objective
To determine the efficacy of chromium picolinate in reducing the clinical severity of acanthosis nigricans and improving insulin resistance in Iraqi adolescents and report any adverse effects.
Methods
95 adolescent patients with insulin resistance and acanthosis nigricans were randomly allocated into two groups in a 1:1 ratio. Group I (n=48) received chromium supplementation for 24 weeks, while Group II (n=47) received identical placebo capsules for the same duration. Changes in the baseline insulin resistance status and Acanthosis Nigricans severity were then recorded during follow-up visits at 8, 16, and 24 weeks.
Results
Chromium supplementation significantly reduced Burke scores from baseline (mean 8.96±2.00) to 24 weeks (5.45±2.14) compared to placebo (9.04±1.92 to 8.00±1.88. HOMA-IR decreased markedly in the chromium group (4.10±0.92 to 2.75±0.89) versus placebo (3.96±0.84 to 3.62±0.85). Changes in HOMA-IR and Burke scores were strongly correlated (r=0.749, p
Zitieren
APA
Abd-Alhussain, G. K. (2026). Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents with Insulin Resistance. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 10(2), 184-191. https://doi.org/10.54133/ajms.v10i2.2841
Vancouver
Abd-Alhussain GK. Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents with Insulin Resistance. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 2026;10(2):184-191. doi:10.54133/ajms.v10i2.2841
BibTeX
@article{AbdAlhussain2026,
author = {Abd-Alhussain, Ghasak Kais},
title = {Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents with Insulin Resistance},
journal = {Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )},
year = {2026},
volume = {10},
number = {2},
pages = {184--191},
doi = {10.54133/ajms.v10i2.2841}
}
EUVIMED